Laboratory strains of Bacillus subtilis encodes as many as 16 alternative sigma factors, 25 each dedicated to expressing a unique regulon such as those involved in stress 26 resistance, sporulation, and motility. The ancestral strain of B. subtilis also encodes an 27 additional sigma factor homolog, ZpdN, not found in lab strains due to it being encoded 28 on the large, low copy number plasmid pBS32 that was lost during domestication. DNA 29 damage triggers pBS32 hyper-replication and cell death in a manner that depends on 30
IMPORTANCE 44
Sigma factors are utilized by bacteria to control and regulate gene expression. Extra 45 cytoplasmic function sigma factors are activated during times of stress to ensure the 46 survival of the bacterium. Here, we report the presence of a sigma factor that is 47 encoded on a plasmid that leads to cellular death after DNA damage. 48
49

INTRODUCTION
dilutions of SPP1 phage stock were added. This mixture was allowed to statically 164 incubate at 37°C for 15 minutes. A 3 ml volume of TYSA (molten TY with 0.5% agar) 165 was added to each mixture and poured on top of fresh TY plates. The plates were 166 incubated at 37 °C overnight. Plates on which plaques formed had the top agar 167
harvested by scraping into a 50 ml conical tube. To release the phage, the tube was 168 vortexed for 20 seconds and centrifuged at 5,000 x g for 10 minutes. The supernatant 169 was passed through a 0.45 m syringe filter and stored at 4 °C. 170
Recipient cells were grown in 2 ml of TY broth at 37 °C until stationary phase 171 was reached. A 5 µl volume of SPP1 donor phage stock was added to 0.9 of cells and 9 172 ml of TY broth was added to this mixture. The transduction mixture was allowed to 173 stand statically at room temperature for 30 minutes. After incubation, the mixture was 174 centrifuged at 5,000 x g for 10 minutes, the supernatant was discarded, and the pellet 175 was resuspended in the volume left. 100 -200 µl of the cell suspension was plated on 176 TY fortified with 1.5% agar, 10 mM sodium citrate, and the appropriate antibiotic for 177
selection. 178 179
Protein Purification. 180
To create the SUMO-SigN fusion protein expression vector, the coding sequence 181 of SigN was amplified from 3610 genomic DNA with primers that also introduced a SapI 182 site at the 5' end and a BamHI site at the 3' end. This fragment was ligated into the SapI 183
and BamHI sites of pTB146 to create pBM05. 184
To purify SigN, pBM05 was expressed in Rosetta Gami II cells and grown at 37 185 °C until mid-log phase (~0.5 OD 600 ). IPTG was added to the cells to induce proteinexpression and cells were allowed to grow overnight at 16 °C. Cells were harvested by 187 centrifugation, washed, and emulsified with EmulsiFlex-C3 (Avestin). Lysed cells were 188 ultracentrifuged at 14,000 x g for 30 minutes at 4˚C.The supernatant was mixed with 189 Ni 2+ -NTA HisBind resin (EMD Millipore) equilibrated with Lysis/Binding Buffer (50 mM 190 Na 2 HPO 4 , 300 mM NaCl, 10 mM Imidazole, final pH 7.5) and allowed to incubate 191 overnight at 4˚C. The bead/lysate mixture was allowed to pack in a 1 cm separation 192 column (Bio-Rad) and washed with Wash Buffer (50 mM Na 2 HPO 4 , 300 mM NaCl, 30 193 mM Imidazole, final pH 7.5). His-SUMO-SigN bound to the resin and was eluted using a 194 stepwise elution of Wash Buffer with 50 -500 mM Imidazole and 10% glycerol to a final 195 To create the SUMO-LexA fusion protein expression vector, the coding sequence 218 of LexA was amplified from 3610 genomic DNA with primers that also introduced a SapI 219 site at the 5' end and a BamHI site at the 3' end. This fragment was ligated into the SapI 220
and BamHI sites of pTB146 to create pATB11. 221
For the purification of LexA, pATB11 was expressed in Rosetta Gami II cells and 222 grown at 37 °C until mid-log phase (~0.5 OD 600 ). Cells were treated the same as in the 223 protein purification procedure for SigN (above). 224 225 SigN Antibody Purification. One milligram of purified SigN protein was sent to 226
Cocalico Biologicals for serial injection into a rabbit host for antibody generation. Anti-227
SigN serum was mixed with SigN-conjugated Affigel-10 beads and incubated overnight 228 at 4˚C. Beads were packed onto a 1 cm column (Bio-Rad) and washed with 100mM 229 glycine (pH 2.5) to release the antibody and neutralized immediately with 2M Tris base. 230
The antibody was verified using SDS-PAGE and stained with Coomassie Brilliant BluePurified anti-SigN antibody was dialyzed into 1X PBS with 50% glycerol and stored at -232
20˚C. 233
Western blotting. B. subtilis strains were grown in LB and treated with Mitomycin C 235 (final concentration 0.3 g/ml) as reported in Myagmarjav, et al 2016. Cells were 236 harvested by centrifugation at the different time points after treatment. Cells were 237 resuspended to 10 OD 600 in Lysis buffer [20 mM Tris-HCL (pH 7.0), 10 mM EDTA, 1 238 mg/ml lysozyme, 10 g/ml DNAse I, 100 g/ml RNAse I, 1 mM PMSF] and incubated for 239 1 hour at 37°C. 20 l of lysate was mixed with 4 l 6x SDS loading dye. and treated with Mitomycin C to a final concentration of 0.3 g/ml. Cells were allowed to 249 grow, and 1 ml was harvested by centrifugation at the different time points indicated 250 after treatment. When IPTG (final concentration 1mM) was used, cells grew to an OD 600 251 0.6 and 1 ml was harvested. Cells were resuspended in 1 ml of Z-buffer (40 mM 252 NaH 2 PO 4 , 60 mM Na 2 HPO 4 , 1mM MgSO 4 , 10 mM KCl, and 38 mM -mercaptoethanol) 253 with 0.2 mg/ml of lysozyme and incubated at 30 C for 15 minutes. Each sample wasdiluted accordingly with Z-buffer to 500 l. The reaction was started with 100 l of 4 255 mg/ml O-nitrophenyl -D-galactopyranoside (in Z buffer) and stopped with 1M Na 2 CO 3 256 (250 l). The OD 420 of each reaction was noted and the -galactosidase specific activity 257 was calculated using this equation: [OD 420 /(time x OD 600 )] x dilution factor x 1000. 258
259
Collection of cells for Rend-seq: 260
Overnight cultures were back diluted 1:100 in LB and grown at 37 C shaking. 261
When the cultures reached an OD600 of 0.1 they were treated with either 1 ug/ml MMC 262 (DK297 and DK3287) or 1mM IPTG (DK1634). The zpdN over expression strain was 263 harvested 1 hour after induction by IPTG. Cells treated with MMC were collected after 2 264 hours. After treatment, 10 ml of each culture was mixed with 10 ml of ice cold methanol 265 and spun down at 3220 ×g at 4 °C for 10 minutes. Supernatant was discarded and cell 266 pellets were frozen in liquid nitrogen and stored at -80°C. For RNA extraction, the 267 thawed pellets were resuspended in 1 ml of Trizol reagent (Thermo Fisher, Waltham,RNA was prepared for Rend-seq as described in detail in Lalanne et ThermoFisher). RNA fragments were dephosphorylated using T4 polynucleotide kinase 285 (New England Biolabs, Ipswitch, MA), precipitated, and ligated to 5' adenylated and 3'-286 end blocked linker 1 (IDT 5 μM) using T4 RNA ligase 2, truncated K227Q. The ligation 287 was carried out at 25°C for 2.5 hours using <5 pmol of dephosphorylated RNA in the 288 presence of 25% PEG 8000 (ThermoFisher). cDNA was prepared by reverse 289 transcription of ligated RNA using Superscript III (ThermoFisher) at 50°C for 30 min. 290 with primer oCJ485 (IDT, Coralville, Iowa) and the RNA was hydrolyzed. cDNA was 291 isolated by PAGE size excision (10% TBE-Urea, 200V, 80 min., ThermoFisher). Single 292 stranded cDNAs were circularized using CircLigase (Illumina, San Diego, CA) at 60°C 293 for 2 hours. Circularized cDNA was the template for PCR amplification using Phusion 294 DNA polymerase (New England Biolabs) with Illumina sequencing primers, primer o231 295 (IDT) and barcoded indexing primers (IDT). After 6 -10 rounds of PCR amplification, 296 the product was selected by size from a non-denaturing PAGE (8% TB, 45 min., 180V, 297
Life Technologies. For dataset names and barcode information see Table S3 . by the peak's enrichment factor to produce the final normalized and shadow removed 311 wig files. Gene regions were plotted in MATlab. 312 purified LexA protein (either 1, 5, 10 , 50, 100, or 500 nM). Reactions were carried out in 324 binding buffer (100 mM HEPES pH 7.5, 100 mM Tris-HCl, 50% glycerol, 500 mM NaCl, 325 10 mM EDTA, 10 mM DTT) supplemented with 100 g/ml bovine serum albumin (BSA) 326 and 10 ng/l poly(dI-dC). All reactions were incubated for 45 minutes at room 327 temperature. Protein-DNA complexes were resolved on a 6% TGE polyacrylamide gel. 328
Gels were dried at 80°C for 90 minutes and exposed to a storage phosphor screen 329 overnight. Gels were imaged with a Typhoon 9500 (GE Life Sciences). As with loss of OD, mutation of sigN abolished the MMC-dependent decrease in cell 361 viability (Fig 1B) . We conclude that pBS32-mediated cell death occurs prior to, and 362 independent of, transient cell growth and the subsequent decline in OD, and that SigN 363 is required for all pBS32-dependent death-related phenotypes thus far observed. 364
To determine if and when SigN was expressed relative to MMC treatment, 365
Western blot analysis was conducted. SigN protein was first detected one hour after 366 MMC treatment and continued to increase in abundance thereafter, whereas the 367 vegetative sigma factor, SigA ( A ), was constitutive and did not increase (Fig 1C) . We 368 noted that loss of cell viability appeared to occur soon after MMC addition, perhaps prior 369 to observable SigN protein (e.g. 0.5 hrs. after addition, Fig 1B) , and thus we inferred 370 that SigN was expressed and active at levels below the limit of protein detection. Tointergenic region of sigN (P sigN ) (Fig 2A) was cloned upstream of the gene encoding β-373 galactosidase, lacZ, and inserted at an ectopic site in the chromosome (aprE::P sigN -374 lacZ). Expression from P sigN was low but increased 10-fold within an hour after MMC 375 addition (T 1 ), and the increase in expression was not dependent on the presence of 376 pBS32 (Fig 3A) . 377
To map the MMC-response within the sigN promoter region, we split the P sigN 378 region into two fragments, an upstream fragment called P sigN UP and a downstream 379 fragment called P sigN DN (Fig 2A) . Both fragments were cloned upstream of lacZ and 380 separately integrated into an ectopic site of the chromosome in a strain deleted for 381 pBS32 and both chromosomal prophages, PBSX and SP. Basal expression from 382 P sigN UP was at background levels but increased 100-fold when MMC was added (Fig  383   3B ). In contrast, expression from P sigN DN was expressed at a constitutively low level and 384 did not increase upon addition of MMC (Fig. 3B) . We conclude that transcription of 385 sigN is activated by MMC treatment, that the P sigN UP region contains an MMC-386 responsive promoter, and that MMC-dependent expression was controlled by a 387 chromosomally-encoded regulator as induction was not dependent on the presence of 388
pBS32. 389
One candidate for an MMC-responsive, chromosomally-encoded regulator is the 390 transcriptional repressor protein LexA. LexA often binds to sequences that overlaps 391 promoters to inhibit access of RNA polymerase holoenzyme (24, 25), and sequence 392 analysis predicted a putative LexA-inverted repeat binding site located within the P sigN UP 393 fragment (26, 27) (Supp. Fig 1) . Moreover, target promoters are exposed and 394 expression is de-repressed when LexA undergoes auto-proteolysis upon DNA damagelike that caused by MMC (24, 25, 28). To determine if P sigN UP was LexA repressed, 396
LexA was mutated in a background deleted for pBS32 and the two chromosomal 397
prophages, PBSX and SP. Mutation of lexA dramatically increased expression from 398 P sigN UP but not P sigN DN (Fig 3C) . We conclude that LexA either directly or indirectly 399 inhibits expression of a promoter present in P sigN UP . 400
One way that LexA might inhibit expression from P sigN UP is if it bound directly to 401 the DNA. To determine whether LexA bound directly to the P sigN UP region, LexA was 402 purified and added to various labeled DNA fragments in an electrophoretic mobility shift 403 assay (EMSA). Consistent with direct, high-affinity binding, purified LexA caused an 404 electrophoretic mobility shift in both the previously established target promoter P recA (25) 405 (Fig 4A) and the P sigN UP promoter region (Fig 4B) at protein levels as low as 1 nM. LexA 406 binding was specific as the affinity was reduced 500-fold for the P sigN DN promoter (Fig  407   4C) . Moreover, LexA binding was specific for the putative LexA inverted repeat 408 sequence as mutation of the sequence (GAAC > TTAC) within P sigN UP reduced binding 409 affinity 100-fold (Fig 4D) . We conclude that LexA binds to the P sigN UP promoter region 410 and represses transcription. 411
LexA often binds overtop of promoter elements (16), and sequence analysis 412 suggested that the LexA inverted repeat in P sigN UP might rest immediately upstream of, 413
an overlap with, a putative SigA-dependent -35 promoter element (Fig 2B) . To 414 determine whether P sigN UP contained a SigA-dependent promoter, RNA polymerase 415 (RNAP) holoenzyme with SigA bound was purified from B. subtilis and used in an independent promoter control P veg (Fig 5A, left lane) , or the experimental P sigN UP (Fig 5B,  419 left lane). A transcription product was also observed when SigA-RNAP was mixed with 420 the P sigN DN promoter fragment (Fig 5C, left lane) , consistent with low level constitutive 421 expression observed from reporters with that fragment (Fig 3B) . We conclude that there 422 are two SigA-dependent promoters within the P sigN region, one within the P sigN UP 423 fragment and one within P sigN DN fragment. 424
To determine transcriptional start sites, Rend-seq (end-enriched RNA-seq) 425 analysis was performed for the entire B. subtilis transcriptome in the presence and 426 absence of MMC-treatment (Fig 2B) . Rend-seq achieves end-enrichment by sparse 427 fragmentation of extracted RNAs, which generates fragments containing original 5' and 428 3' ends, as well as a lower amount of fragments containing internal ends (29, 30) . Rend-429 seq indicated that expression of sign was low in the absence of induction (Fig 2C) but a 430 5' end appeared within the P sigN UP region when MMC was added, the location of which 431 was consistent with the SigA -10 promoter element predicted earlier (Fig 2B) and 432 supported later by in vitro transcription (Fig 5A, left lane) . We define the SigA-433 dependent promoter within P sigN UP as P sigN1 . Rend-seq also indicated a weak but MMC-434 independent 5' end within P sigN DN that was consistent with the in vitro transcription 435 product originating from that fragment (Fig 5B, left lane) . Moreover, sequences 436 consistent with -35 and -10 promoter elements were identified upstream of the 5' end 437 within P sigN DN (Fig 2B) . We define the weak constitutive SigA-dependent promoter 438 within P sigN DN as P sigN2 . We conclude that there are two SigA-dependent promoters 439 driving sigN expression, and that P sigN1 is both strong and LexA-repressed.
SigN is a sigma factor that activates its own expression. Rend-seq analysis also 442 indicated a second 5' end within P sigN DN fragment that would result in a slightly shorter 443 transcript (Fig 2B, peak marked P ? ). The shorter transcript could indicate either a highly 444 specific RNA cleavage site in the 5' upstream untranslated region of sigN, or the 445 presence of a third promoter with an individual start site. If there was a second promoter 446 within P sigN DN , the promoter was presumably not dependent on SigA as only one SigA-447 dependent transcript was observed from this fragment in in vitro transcription assays 448 (Fig 5B) . One candidate for an alternative sigma factor that could drive expression of 449 the third putative promoter is SigN itself. SigN is homologous to extra-cytoplasmic 450
function (ECF) sigma factors and ECF sigma factors are often autoregulatory (31). 451
Consistent with autoactivation, induction of SigN increased expression from P sigN DN -lacZ 452 100-fold but did not increase expression from P sigN UP (Fig 3C) . We conclude that sigN 453 expression is controlled by at least three promoters: a LexA-repressed SigA-dependent 454 promoter P sigN1 , a weak constitutive SigA-dependent promoter P sigN2 , and a third 455 promoter that was SigN-dependent. 456
One way in which a promoter could be SigN-dependent is if SigN is a bona fide 457 sigma factor that directs its transcription. To determine whether SigN had sigma factor 458 activity, RNAP-SigA holoenzyme was purified from B. subtilis and purified SigN protein 459 was added in 5-fold excess in in vitro transcription reactions(32-34). Addition of SigN 460 reduced levels of the SigA-dependent P veg , P sigN1 , and the P sigN2 -derived transcripts, 461 consistent with SigN competing with, and displacing, SigA from the RNA polymerase 462 core (Fig. 5, right lanes) . Moreover, a new shorter transcript appeared within P sigN DN that 463
Rend-seq was conducted on a strain that was artificially induced for SigN expression. 465
Consistent with the in vitro transcription results, an intense SigN-dependent 5' end was 466 detected within the P sigN DN region which we infer is due to the presence of a promoter 467 here called, P sigN3 (Fig 2C) . We note that the P sigN3 -dependent transcript did not align 468 with the original transcript peak from P ? indicated by Rend-seq analysis and thus at 469 least three and possibly more promoters may be present upstream of sigN. Moreover, 470 both the P ? and P sigN3 -dependent peaks in the MMC-treated REND-seq, were abolished 471 in sigN mutant cells (Fig 2C) . Nonetheless, we conclude that SigN is a bona fide sigma 472 factor that is necessary and sufficient for inducing expression from P sigN3 . 473
Mapping of the Rend-seq transcriptional start site, allowed prediction of the P sigN3 474 promoter sequence (Fig 2B) . To determine a SigN consensus sequence, 40 base pairs 475 of sequence upstream of each pBS32 5' end of transcript as determined by Rend-seq 476 analysis after SigN artificial expression were collected and compiled by MEME (35) (Fig  477   2D) . A consensus sequence emerged that was consistent with the -35 and -10 regions 478 predicted by distance analysis for P sigN3 (Fig 2B) . Three separate promoter regions 479 predicted thought to be regulated by SigN were cloned upstream of a promoter-less 480 lacZ gene and inserted at an ectopic site in the chromosome in a strain deleted for 481 pBS32. In each case, the expression of the reporter was low during normal growth 482 conditions but increased 100-fold when sigN was induced with IPTG ( Fig 3E) . We 483 conclude that SigN is a plasmid-encoded sigma factor that is necessary and sufficient 484 for the expression of a regulon genes encoded on pBS32, and we infer that the 485 expression of one or more genes within the SigN regulon is responsible for pBS32-486 mediated cell death. show that SigN exhibits sigma factor activity in vitro. Moreover, using Rend-seq analysis 493 we determine the regulon of genes under SigN control and use transcriptional start sites 494 and to identify a consensus binding sequence (Fig 2C) . While plasmid-encoded sigma 495 factors are rare, SigN is conserved on Bacillus plasmids that are closely related to 496 pBS32 such as pLS32 or pBUYP1. Alternative sigma factors or analogs thereof are 497 sometimes encoded within prophage elements (36-39), and pBS32 encodes what 498 appears to be a cryptic prophage. Whether pBS32 in its entirety is a P1-like plasmid 499
prophage (40),or whether a phage secondarily lysogenized into a preexisting plasmid is 500 unknown but pBS32 in its entirety appears to be released on cell death in a capsid-501 dependent DNase-resistant form (17). Regardless, induction of SigN is necessary and 502 sufficient to cause cell death in a manner dependent on pBS32. 503 Similar to, and perhaps consistent with, other lysogenic prophages in B. subtilis, 504 DNA damage caused by MMC triggers hyper-replication of pBS32 and initiates pBS32-505 mediated cell death (16, 17, 41). Here we show that MMC induces the plasmid via the 506 chromosomally-encoded transcriptional repressor LexA (Fig 6) . LexA tightly represses 507 the P sigN1 promoter, and MMC-mediated DNA damage promotes the auto-proteolysis of 508
LexA (28, 42-44). De-repression of P sigN1 leads to high-level sigN expression and once 509 expressed, SigN locks the system into an activated state by positive feedback at the 510 P sigN3 promoter. SigN directs not only its own expression but an entire regulon on pBS32 511 which includes many genes homologous to those involved in nucleotide metabolism andDNA replication (Table 2) . Thus, SigN activation cause pBS32 copy number to increase 513 100-fold and either directly or indirectly promote cell death. 514
How pBS32 actually kills cells is still unknown. Here we show that cells activated 515
for SigN in the presence of pBS32 continue to grow for three generations even as cell 516 viability rapidly declines. Thus, toxicity likely isn't due to direct inhibition of essential 517 components and instead, something essential is depleted, diluted through growth and 518 not replaced. Hyper-replication of the plasmid may deplete nucleotide pools but at 519 present we cannot determine whether hyper-replication and death are linked or 520 separate phenotypes. Finally, death might be mediated by the prophage structural and 521 lytic genes, but we note that SigN-dependent promoters appear to be largely excluded 522 from the prophage region and while prophage gene expression increases, the increase 523 may be largely due to the increase in plasmid copy number. Finally, large deletions of 524 the prophage structural genes were insufficient to abolish pBS32-mediated cell death 525 (17). Thus, prophage gene expression may be separate from SigN-mediate death as 526
well. 527
Members of the extracytoplasmic sigma factor (ECF) family are typically induced 528 by extracellular signals and promote gene expression to adapt to environment stress 529 (45, 46). Here we show that SigN is a functional ECF-like sigma that responds to 530 internal signals in the form of DNA damage and in turn, promotes cell death. Why cells 531 encode a sigma factor that induces cell death is unknown. Moreover, SigN appears to 532 be unlike most ECF sigma factors as it does not appear to be regulated by a co-533 expressed cognate anti-sigma. Thus, if and how SigN is regulated independently of the 534 DNA damage response, is unknown. We note however that there is a third weak butconstitutive promoter P sigN2 that also drives expression of SigN. The function of P sigN2 536 and why P sigN2 is insufficient to promote SigN-mediated cell death is unknown. We 537 speculate however, that P sigN2 may either provide for additional environmental regulation 538 on SigN or be an irrelevant vestige of former regulation. Ultimately, why B. subtilis 539 retains a potentially lethal plasmid and a sigma factor that promotes cell death is 540 consensus sequence generated by MEME sequence analysis using the promoters 705 listed in Table 2 . resulting from P sigN1 , P sigN2 , and P sigN4 are indicated. Two products were observed from 740 P veg likely due to proper termination (short product) and terminator read-through (long 741 product). 
